Yael Stern

1.1k total citations
15 papers, 679 citations indexed

About

Yael Stern is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Yael Stern has authored 15 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Rheumatology. Recurrent topics in Yael Stern's work include Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Yael Stern is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (6 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Yael Stern collaborates with scholars based in Israel. Yael Stern's co-authors include Mark Dolev, Anat Achiron, David Magalashvili, Michael Gurevich, Shay Menascu, Yoram Barak, Michael Polliack, Mordechai Dulitzky, Eyal Schiff and R. Achiron and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and Journal of the Neurological Sciences.

In The Last Decade

Yael Stern

15 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yael Stern Israel	11	526	258	170	132	67	15	679
Sonu M. Brara United States	8	436 0.8×	152 0.6×	66 0.4×	117 0.9×	98 1.5×	11	667
Hesham Abboud United States	19	456 0.9×	589 2.3×	157 0.9×	73 0.6×	106 1.6×	58	887
David Magalashvili Israel	16	810 1.5×	385 1.5×	441 2.6×	222 1.7×	84 1.3×	48	1.1k
Kévin Bigaut France	12	379 0.7×	374 1.4×	337 2.0×	66 0.5×	39 0.6×	28	671
Joana Hygino Brazil	18	358 0.7×	109 0.4×	65 0.4×	359 2.7×	59 0.9×	29	924
Shlomo Flechter Israel	15	606 1.2×	320 1.2×	433 2.5×	294 2.2×	74 1.1×	39	1.0k
Pål Berg‐Hansen Norway	16	475 0.9×	148 0.6×	38 0.2×	118 0.9×	117 1.7×	40	699
Katelyn Kavak United States	12	369 0.7×	120 0.5×	38 0.2×	68 0.5×	70 1.0×	32	506
Mehri Salari Iran	15	219 0.4×	318 1.2×	135 0.8×	47 0.4×	39 0.6×	92	662
Antonio Cortese Italy	14	307 0.6×	144 0.6×	38 0.2×	58 0.4×	71 1.1×	25	463

Countries citing papers authored by Yael Stern

Since Specialization

Citations

This map shows the geographic impact of Yael Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yael Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yael Stern more than expected).

Fields of papers citing papers by Yael Stern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yael Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yael Stern. The network helps show where Yael Stern may publish in the future.

Co-authorship network of co-authors of Yael Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Yael Stern. A scholar is included among the top collaborators of Yael Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yael Stern. Yael Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dreyer-Alster, Sapir, Shay Menascu, Mathilda Mandel, et al.. (2022). COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose. Journal of the Neurological Sciences. 434. 120155–120155. 40 indexed citations

Achiron, Anat, et al.. (2022). Unique features of central neuropathic pain in multiple sclerosis: Results of a cluster analysis. European Journal of Pain. 26(5). 1107–1122. 16 indexed citations

Achiron, Anat, Sapir Dreyer-Alster, Michael Gurevich, et al.. (2021). Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression. Multiple Sclerosis and Related Disorders. 50. 102814–102814. 3 indexed citations

Achiron, Anat, Mark Dolev, Shay Menascu, et al.. (2021). COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Multiple Sclerosis Journal. 27(6). 864–870. 146 indexed citations

Achiron, Anat, et al.. (2021). Central Neuropathic Pain in Multiple Sclerosis Is Associated with Impaired Innocuous Thermal Pathways and Neuronal Hyperexcitability. Pain Medicine. 22(10). 2311–2323. 12 indexed citations

Achiron, Anat, Alon Ben‐David, Michael Gurevich, et al.. (2020). Parity and disability progression in relapsing–remitting multiple sclerosis. Journal of Neurology. 267(12). 3753–3762. 12 indexed citations

Achiron, Anat, I Sarova-Pinhàs, David Magalashvili, et al.. (2018). Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy. Multiple Sclerosis Journal. 25(13). 1746–1753. 12 indexed citations

Achiron, Anat, Rina Zilkha‐Falb, David Magalashvili, et al.. (2016). Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients. Journal of NeuroVirology. 22(6). 736–746. 3 indexed citations

Kalron, Alon, David Magalashvili, Mark Dolev, et al.. (2015). A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort. BMC Neurology. 15(1). 21–21. 27 indexed citations

10.

Gurevich, Michael, Rina Falb, David Magalashvili, et al.. (2015). Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis. BMC Neurology. 15(1). 240–240. 8 indexed citations

11.

Achiron, Anat, Uri Givon, David Magalashvili, et al.. (2014). Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study. Multiple Sclerosis Journal. 21(6). 767–775. 60 indexed citations

12.

Achiron, Anat, Joab Chapman, David Magalashvili, et al.. (2013). Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study. PLoS ONE. 8(8). e71058–e71058. 119 indexed citations

13.

Achiron, Anat, I Sarova-Pinhàs, Meir Faibel, et al.. (2004). Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis. Archives of Neurology. 61(10). 1515–1515. 74 indexed citations

14.

Achiron, Anat, Mark Dolev, Yael Stern, et al.. (2004). Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. Journal of Neurology. 251(9). 1133–7. 141 indexed citations

15.

Schuldiner, Shimon, et al.. (1985). The Amine Transporter from Bovine Chromaffin Granules^a. Annals of the New York Academy of Sciences. 456(1). 268–276. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact